Microglia in gemistocytic astrocytomas

Area of Science:

• Neuro-oncology
• Immunology
• Tumor Biology

Background:

• Gemistocytic astrocytomas (WHO II) exhibit aggressive behavior despite low proliferation.
• These tumors show high P53 mutation rates, cytological abnormalities, and mononuclear infiltrates.
• Microglial cells are increasingly recognized for their role in glioma progression.

Purpose of the Study:

• To investigate the presence and role of microglial cells in gemistocytic astrocytomas.
• To explore the relationship between microglial cells, tumor cells, and major histocompatibility complex (MHC) Class II expression.

Main Methods:

• Analysis of 23 gemistocytic astrocytoma biopsies.
• Immunolabeling for microglial markers (CR3/43, Ki-M1P, iba1).
• In situ hybridization for MHC Class II alpha-chain expression on tumor cells.

Main Results:

• Gemistocytic astrocytomas exhibit a high density of microglial cells.
• Microglia numbers positively correlated with the fraction of gemistocytic tumor cells.
• Gemistocytic tumor cells showed aberrant MHC Class II expression, inversely correlating with the number of MHC Class II-positive microglia.

Conclusions:

• Gemistocytic astrocytomas harbor a significant number of microglial cells.
• Aberrant MHC Class II expression by gemistocytic cells may lead to a loss of immune-competent microglia.
• This immune dysregulation could contribute to the poor prognosis associated with gemistocytic astrocytomas, possibly via T cell anergy induction.